Efficacy and safety of sofosbuvir and daclatasvir in patients with chronic hepatitis C virus induced cirrhosis with Child-Pugh class B

Efficacy and safety of sofosbuvir and daclatasvir in patients with chronic hepatitis C virus induced cirrhosis with Child-Pugh class B

Abstract Background This study aimed to evaluate the efficacy, safety and tolerability of SOF/DCV ± RBV in a cohort of Egyptian patients with chronic hepatitis C (CHC)-induced cirrhosis with decompensation (class B7–B9). Results After excluding the 9 patients who withdrew, SVR12 rate according to pe...

Full description

Bibliographic Details
Main Authors: Mayssa El Raziky, Sherif Hamdy, Yasser Hamada, Nermin Mohamed Abdelaziz, Mohamed Hassany, Wahid Doss, Zeinab Zakaria
Format: Article
Language:English
Published: SpringerOpen 2022-01-01
Series:Egyptian Liver Journal
Subjects:
Chronic hepatitis C-induced cirrhosis
Mild decompensation
SOF/DCV
SVR12
Online Access:https://doi.org/10.1186/s43066-022-00174-3

Internet

https://doi.org/10.1186/s43066-022-00174-3

Similar Items